Viactiv partners with Susan G. Komen for the Cure, continuing its ‘Style and Strength for Life’ Campaign
NEW YORK A calcium supplement brand has become a sponsor of Susan G. Komen for the Cure, the world’s largest breast cancer organization.
Viactiv Calcium Soft Chews, which contain 125% of the daily value of vitamin D, pledged a sponsorship of $100,000 between August 2008 and July 2009. The brand’s sponsorship is part of the year-long “Style and Strength for Life” campaign, which is built on an innovative platform uniting the Viactiv brand with breakout fashion designer Ashleigh Verrier and her mother and business partner Jude Verrier. The initiative was established to educate women about the connection between adequate calcium, essential vitamins (particularly vitamin D) and healthy beauty.
As part of its “Style and Strength for Life” campaign, and serving as the cornerstone of its Susan G. Komen for the Cure partnership, the Viactiv will also appear as one of the “silver-level” sponsors of the Komen Philadelphia Race for the Cure this May. The race will take place on May 10 at 8:15 a.m. at Eakins Oval at the Philadelphia Art Museum. The brand, along with Ashleigh and Jude Verrier, will inspire walkers to pledge their “daily promise to be strong.” Each promise, written on a special hangtag, will come together to create a powerful display of strength.
Additionally, limited-edition “My Daily Promise” bracelets, designed by Ashleigh Verrier, will be awarded to participants and spectators via a random drawing during the race. Consumers will also have the opportunity to enter an online contest in May at www.viactiv.com for their chance to win a limited-edition bracelet. The “My Daily Promise” bracelet, a ring of silver beads and one standout bead encrusted with brilliant purple Swarovski crystals accompanied by a chic “V” charm, was developed earlier this year — and gifted to various celebrities during Mercedes-Benz Fashion Week — to bring the message of healthy beauty to life. The “My Daily Promise” bracelet serves as a stylish reminder to take Viactiv Calcium supplements each day as a commitment to healthy beauty and wellness.
Atherotech’s new cholesterol test showcased at Internal Medicine 2009
BIRMINGHAM, Ala. Atherotech, Inc. announced Monday it will be exhibiting its VAP Cholesterol Test at Internal Medicine 2009, the annual scientific meeting of the American College of Physicians.
The conference takes place April 23 to April 25, at the Pennsylvania Convention Center in Philadelphia.
Used in more than 100 clinical trials, including the Heredity and Phenotype Intervention Heart Study, recently published in Science, the Vertical Auto Profile Test claims to be the most accurate cholesterol test available.
The VAP Test reports 20 separate components of blood cholesterol as opposed to four in a standard test and can identify a far great number of lipid abnormalities (the #1 risk factor for heart disease) than the standard cholesterol test. The test identifies markers for metabolic syndrome, a precursor for diabetes, and is the only single cholesterol test that routinely reports apoAI, apoB, and the apoB/apoAI ratio.
The VAP Test provides physicians and researchers with direct measurement of LDL, HDL and all relevant subclasses, non-HDL and emerging risk factors such as Lp(a), remnants and small dense LDL.
Atherotech recently announced the addition of more than a dozen tests for patients at intermediate to high risk of cardiometabolic diseases. The new test panels are available immediately and also include homocysteine, creatinine, creatine kinase (CK), HbA1c, TSH, ALT, AST, urea nitrogen (BUN), glucose, vitamin D, fibrinogen and insulin. The tests can be ordered individually, or bundled as part of a custom risk profile that may also include the VAP Test.
People with a family history or an existing condition of diabetes, high blood pressure or heart disease – or who are already taking cholesterol-lowering medication – are candidates for the comprehensive VAP Test.
Innovative Custom Products acquires Scent to Sleep
MILWAUKEE Innovative Custom Products, Inc., a developer and distributor of over-the-counter pharmaceuticals, announced that it has acquired Scent To Sleep, a Calif.-based company. Scent To Sleep manufactures and distributes a revolutionary All Natural Non-Drowsy Sleep Mist.
Scent To Sleep is all-natural, safe, environmentally-friendly and one of the most innovative non-prescription sleep aids to hit the market. Its proprietary formulation contains no chemicals or harmful ingredients, or prescription side effects.
Scent To Sleep is expected to roll out in some retail chains later this year. In the meantime, consumers can purchase Scent To Sleep at www.drmistICP.com, the corporation’s e-commerce Web site. Scent To Sleep is available in Luscious Lavender Scent and Decadent Green Apple with Vanilla, backed by the company’s 100% Money-Back Guarantee, and retails for $11.99.